{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:35:00Z","timestamp":1769600100000,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1752-1947-8-429","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T06:45:40Z","timestamp":1434609940000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical considerations in transitioning patients with epilepsy from clonazepam to clobazam: a case series"],"prefix":"10.1186","volume":"8","author":[{"given":"Raman","family":"Sankar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael Scott","family":"Perry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben","family":"Kuzniecky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saurabh","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,16]]},"reference":[{"key":"3028_CR1","first-page":"99","volume":"112","author":"H Gastaut","year":"1965","unstructured":"Gastaut H, Roger J, Soulayrol R, Lob H, Tassinari CA: L\u2018action du diazepam (Valium) dans le traitement des formes non-convulsives de l\u2019\u00e9pilepsie g\u00e9n\u00e9ralis\u00e9e. Rev Neurol (Paris). 1965, 112: 99-118.","journal-title":"Rev Neurol (Paris)"},{"key":"3028_CR2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1528-1157.1965.tb03786.x","volume":"6","author":"H Gastaut","year":"1965","unstructured":"Gastaut H, Naquet R, Poir\u00e9 R, Tassinari CA: Treatment of status epilepticus with diazepam (Valium). Epilepsia. 1965, 6: 167-182. 10.1111\/j.1528-1157.1965.tb03786.x.","journal-title":"Epilepsia"},{"key":"3028_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1528-1157.1971.tb04928.x","volume":"12","author":"H Gastaut","year":"1971","unstructured":"Gastaut H, Courjon J, Poire R, Weber M: Treatment of status epilepticus with a new benzodiazepine more active than diazepam. Epilepsia. 1971, 12: 197-214. 10.1111\/j.1528-1157.1971.tb04928.x.","journal-title":"Epilepsia"},{"key":"3028_CR4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1001\/archneur.1976.00500050012003","volume":"33","author":"TR Brown","year":"1976","unstructured":"Brown TR: Clonazepam: a review of a new anticonvulsant drug. Arch Neurol. 1976, 33: 326-332. 10.1001\/archneur.1976.00500050012003.","journal-title":"Arch Neurol"},{"key":"3028_CR5","unstructured":"[prescribing information]. Klonopin (Clonazepam). 2010, South San Francisco, CA, USA: Genentech"},{"key":"3028_CR6","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1212\/WNL.0b013e318232de76","volume":"77","author":"YT Ng","year":"2011","unstructured":"Ng YT, Conry JA, Drummond R, Stolle J, Weinberg MA, OV-1012 Study Investigators: Randomized, phase III study results of clobazam in Lennox\u2013Gastaut syndrome. Neurology. 2011, 77: 1473-1481. 10.1212\/WNL.0b013e318232de76.","journal-title":"Neurology"},{"issue":"Suppl 1","key":"3028_CR7","first-page":"S6","volume":"19","author":"R Sankar","year":"2004","unstructured":"Sankar R, Holmes GL: Mechanisms of action for the commonly used antiepileptic drugs: relevance to antiepileptic drug-associated neurobehavioral adverse effects. J Child Neurol. 2004, 19 (Suppl 1): S6-S14.","journal-title":"J Child Neurol"},{"issue":"Suppl 3","key":"3028_CR8","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.yebeh.2004.06.013","volume":"5","author":"TA Glauser","year":"2004","unstructured":"Glauser TA: Effects of antiepileptic medications on psychiatric and behavioral comorbidities in children and adolescents with epilepsy. Epilepsy Behav. 2004, 5 (Suppl 3): S25-S32.","journal-title":"Epilepsy Behav"},{"key":"3028_CR9","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2165\/11599020-000000000-00000","volume":"26","author":"R Sankar","year":"2012","unstructured":"Sankar R: GABAA receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam. CNS Drugs. 2012, 26: 229-244. 10.2165\/11599020-000000000-00000.","journal-title":"CNS Drugs"},{"key":"3028_CR10","doi-asserted-by":"publisher","first-page":"e88456","DOI":"10.1371\/journal.pone.0088456","volume":"9","author":"HS Jensen","year":"2014","unstructured":"Jensen HS, Nichol K, Lee D, Ebert B: Clobazam and its active metabolite N- desmethylclobazam display significantly greater affinities for \u03b12- versus \u03b11-GABAA\u2013receptor complexes. PLoS One. 2014, 9: e88456-10.1371\/journal.pone.0088456.","journal-title":"PLoS One"},{"key":"3028_CR11","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/epi.12561","volume":"55","author":"JA Conry","year":"2014","unstructured":"Conry JA, Ng YT, Kernitsky L, Mitchell WG, Veidemanis R, Drummond R, Isojarvi J, Lee D, Paolicchi JM, and on behalf of the OV-1004 Study Investigators: Stable dosages of clobazam for Lennox\u2013Gastaut syndrome are associated with sustained drop-seizure and total-seizure improvements over 3 years. Epilepsia. 2014, 55: 558-567. 10.1111\/epi.12561.","journal-title":"Epilepsia"},{"key":"3028_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1528-1157.1982.tb05426.x","volume":"23","author":"AK Shenoy","year":"1982","unstructured":"Shenoy AK, Miyahara JT, Swinyard EA, Kupferberg HJ: Comparative anticonvulsant activity and neurotoxicity of clobazam, diazepam, phenobarbital, and valproate in mice and rats. Epilepsia. 1982, 23: 399-408. 10.1111\/j.1528-1157.1982.tb05426.x.","journal-title":"Epilepsia"},{"issue":"Suppl 1","key":"3028_CR13","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1111\/j.1528-1157.1986.tb05728.x","volume":"27","author":"L St\u00e9ru","year":"1986","unstructured":"St\u00e9ru L, Chermat R, Millet B, Mico JA, Simon P: Comparative study in mice of ten 1,4-benzodiazepines and of clobazam: anticonvulsant, anxiolytic, sedative, and myorelaxant effects. Epilepsia. 1986, 27 (Suppl 1): S14-S17.","journal-title":"Epilepsia"},{"key":"3028_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0920-1211(89)90065-X","volume":"3","author":"EI Tietz","year":"1989","unstructured":"Tietz EI, Rosenberg HC, Chiu TH: A comparison of the anticonvulsant effects of 1,4- and 1,5-benzodiazepines in the amygdala-kindled rat and their effects on motor function. Epilepsy Res. 1989, 3: 31-40. 10.1016\/0920-1211(89)90065-X.","journal-title":"Epilepsy Res"},{"key":"3028_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1365-2125.1975.tb01578.x","volume":"2","author":"RG Borland","year":"1975","unstructured":"Borland RG, Nicholson AN: Immediate effects on human performance of a 1,5- benzodiazepine (clobazam) compared with the 1,4-benzodiazepines, chlordiazepoxide hydrochloride and diazepam. Br J Clin Pharmacol. 1975, 2: 215-221. 10.1111\/j.1365-2125.1975.tb01578.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl 1","key":"3028_CR16","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1111\/j.1365-2125.1979.tb04670.x","volume":"7","author":"AN Nicholson","year":"1979","unstructured":"Nicholson AN: Differential effects of the 1,4- and 1,5-benzodiazepines on performance in healthy man. Br J Clin Pharmacol. 1979, 7 (Suppl 1): S83-S84.","journal-title":"Br J Clin Pharmacol"},{"key":"3028_CR17","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1528-1157.1989.tb05299.x","volume":"30","author":"HC Rosenberg","year":"1989","unstructured":"Rosenberg HC, Tietz EI, Chiu TH: Tolerance to anticonvulsant effects of diazepam, clonazepam, and clobazam in amygdala-kindled rats. Epilepsia. 1989, 30: 276-285. 10.1111\/j.1528-1157.1989.tb05299.x.","journal-title":"Epilepsia"},{"key":"3028_CR18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3565(25)21163-6","volume":"279","author":"W L\u00f6scher","year":"1996","unstructured":"L\u00f6scher W, Rundfeldt C, H\u00f6nack D, Ebert U: Long-term studies on anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. I. Comparison of diazepam, clonazepam, clobazam and abecarnil. J Pharmacol Exp Ther. 1996, 279: 561-572.","journal-title":"J Pharmacol Exp Ther"},{"key":"3028_CR19","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/0887-8994(93)90026-9","volume":"9","author":"R Munn","year":"1993","unstructured":"Munn R, Farrell K: Open study of clobazam in refractory epilepsy. Pediatr Neurol. 1993, 9: 465-469. 10.1016\/0887-8994(93)90026-9.","journal-title":"Pediatr Neurol"},{"key":"3028_CR20","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/j.1528-1157.1995.tb01617.x","volume":"36","author":"A Singh","year":"1995","unstructured":"Singh A, Guberman AH, Boisvert D: Clobazam in long-term epilepsy treatment: sustained responders versus those developing tolerance. Epilepsia. 1995, 36: 798-803. 10.1111\/j.1528-1157.1995.tb01617.x.","journal-title":"Epilepsia"},{"key":"3028_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/WNF.0b013e3182770730","volume":"36","author":"EH Lee","year":"2013","unstructured":"Lee EH, Yum MS, Choi HW, Ko TS: Long-term use of clobazam in Lennox\u2013Gastaut syndrome: experience in a single tertiary epilepsy center. Clin Neuropharmacol. 2013, 36: 4-7. 10.1097\/WNF.0b013e3182770730.","journal-title":"Clin Neuropharmacol"},{"key":"3028_CR22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0022-3565(25)22081-X","volume":"227","author":"RM Arendt","year":"1983","unstructured":"Arendt RM, Greenblatt DJ, de Jong RH, Bonin JD, Abernethy DR, Ehrenberg BL, Giles HG, Sellers EM, Shader RI: In vitro correlates of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action and peripheral distribution. J Pharmacol Exp Ther. 1983, 227: 98-106.","journal-title":"J Pharmacol Exp Ther"},{"key":"3028_CR23","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/bja\/55.10.985","volume":"55","author":"DJ Greenblatt","year":"1983","unstructured":"Greenblatt DJ, Arendt RM, Abernethy DR, Giles HG, Sellers EM, Shader RI: In vitro quantitation of benzodiazepine lipophilicity: relation to in vivo distribution. Br J Anaesth. 1983, 55: 985-989. 10.1093\/bja\/55.10.985.","journal-title":"Br J Anaesth"},{"key":"3028_CR24","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00007691-198712000-00001","volume":"9","author":"GM Pacifici","year":"1987","unstructured":"Pacifici GM, Viani A, Rizzo G, Carrai M, Rane A: Plasma protein binding of clonazepam in hepatic and renal insufficiency and after hemodialysis. Ther Drug Monit. 1987, 9: 369-373. 10.1097\/00007691-198712000-00001.","journal-title":"Ther Drug Monit"},{"key":"3028_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1600-0404.2008.01004.x","volume":"118","author":"J Riss","year":"2008","unstructured":"Riss J, Cloyd J, Gates J, Collins S: Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurol Scand. 2008, 118: 69-86. 10.1111\/j.1600-0404.2008.01004.x.","journal-title":"Acta Neurol Scand"},{"issue":"Suppl 1","key":"3028_CR26","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1111\/j.1365-2125.1979.tb04665.x","volume":"7","author":"W Rupp","year":"1979","unstructured":"Rupp W, Badian M, Christ O, Hajdu P, Kulkarni RD, Taeuber K, Uihlein M, Bender R, Vanderbeke O: Pharmacokinetics of single and multiple doses of clobazam in humans. Br J Clin Pharmacol. 1979, 7 (Suppl 1): S51-S57.","journal-title":"Br J Clin Pharmacol"},{"key":"3028_CR27","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/j.1528-1157.1996.tb00643.x","volume":"37","author":"F Nakamura","year":"1996","unstructured":"Nakamura F, Suzuki S, Nishimura S, Yagi K, Seino M: Effects of clobazam and its active metabolite on GABA-activated currents in rat cerebral neurons in culture. Epilepsia. 1996, 37: 728-735. 10.1111\/j.1528-1157.1996.tb00643.x.","journal-title":"Epilepsia"},{"key":"3028_CR28","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/j.1875-9114.2012.01028.x","volume":"32","author":"M Walzer","year":"2012","unstructured":"Walzer M, Bekersky I, Blum RA, Tolbert D: Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes. Pharmacotherapy. 2012, 32: 340-353. 10.1002\/j.1875-9114.2012.01028.x.","journal-title":"Pharmacotherapy"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-8-429.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1752-1947-8-429\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-8-429","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-8-429.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T18:26:40Z","timestamp":1748456800000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/1752-1947-8-429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3028"],"URL":"https:\/\/doi.org\/10.1186\/1752-1947-8-429","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"18 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"429"}}